Infectious Diseases in Obstetrics and Gynecology
Volume 2010 (2010), Article ID 802503, 7 pages
doi:10.1155/2010/802503
Clinical Study

Hepatitis B Response of Premature Infants after Primary and Booster Immunisation with a Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Poliovirus/Haemophilus Influenzae Type B Vaccine

Felix Omeñaca,1 Jose Garcia-Sicilia,2 Reyes Boceta,3 and Pilar García-Corbeira3

1Neonatal Unit, Department of Neonatology, La Paz Hospital, Castellana 261, 28046 Madrid, Spain
2Department of Paediatrics, La Paz Hospital, 28046 Madrid, Spain
3Medical Department, GlaxoSmithKline, Tres Cantos, Madrid, Spain

Received 1 December 2009; Accepted 4 March 2010

Academic Editor: José Tirán-Saucedo

Copyright © 2010 Felix Omeñaca et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. W. Shepard, L. Finelli, A. E. Fiore, and B. P. Bell, “Epidemiology of hepatitis B and hepatitis B virus infection in United States children,” Pediatric Infectious Disease Journal, vol. 24, no. 9, pp. 755–760, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Mast, F. Mahoney, M. Kane, and H. Margolis, “Hepatitis B vaccine,” in Vaccines, S. A. Plotkin and W. A. Orenstein, Eds., pp. 299–337, Elsevier, Philadelphia, Pa, USA, 2004.
  3. M. M. Slattery and J. J. Morrison, “Preterm delivery,” The Lancet, vol. 360, no. 9344, pp. 1489–1497, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. American Academy of Pediatrics, “Immunization in special clinical circumstances,” in Red Book: 2003. Report of the Committee on Infectious Diseases, L. K. Pickering, Ed., pp. 66–68, American Academy of Pediatrics, Elk Grove Village, Ill, USA, 26th edition, 2003.
  5. D. L. Langkamp, S. Hoshaw-Woodard, M. E. Boye, and S. Lemeshow, “Delays in receipt of immunizations in low-birth-weight children: a nationally representative sample,” Archives of Pediatrics and Adolescent Medicine, vol. 155, no. 2, pp. 167–172, 2001. View at Scopus
  6. P. A. Offit, J. Quarles, M. A. Gerber, et al., “Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system?” Pediatrics, vol. 109, no. 1, pp. 124–129, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Omeñaca, J. Garcia-Sicilia, P. Garcia-Corbeira, et al., “Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue,” Pediatrics, vol. 116, no. 6, pp. 1292–1298, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. F. Omeñaca, J. Garcia-Sicilia, P. Garcia-Corbeira, et al., “Immunogenicity of a combined DTPa-HBV-IPV/Hib hexavalent vaccine in preterm infants after primary and booster doses,” in Proceedings of the 43th ICAAC Meeting, Chicago, Ill, USA, November 2003, abstract no. L-186A.
  9. F. Omeñaca, J. Garcia-Sicilia, P. Garcia-Corbeira, R. Boceta, and V. Torres, “Anti-PRP response of premature infants to primary and booster vaccination with a combined diphteria-tetanus-acellular pertussis-hepatitis B-inactiavted polio virus /Haemophilus influenzae type b vaccine,” Pediatrics, vol. 119, pp. e179–e185, 2007.
  10. P. Lumbiganon, P. Kowsuwan, P. Lumbiganon, S. Taksaphan, M. Panamonta, and A. Assateerawatts, “Comparison of immunogenicity of hepatitis B vaccine between low and normal birth weight infants,” Asian Pacific Journal of Allergy and Immunology, vol. 10, no. 1, pp. 61–63, 1992. View at Scopus
  11. D. M. Patel, J. Butler, S. Feldman, G. R. Graves, and P. G. Rhodes, “Immunogenicity of hepatitis B vaccine in healthy very low birth weight infants,” Journal of Pediatrics, vol. 131, no. 4, pp. 641–643, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Belson, S. Reif, Y. Peled, and Y. Bujanover, “Immune response to hepatitis B virus vaccine in 1-year-old preterm and term infants,” Journal of Pediatric Gastroenterology and Nutrition, vol. 23, no. 3, pp. 252–255, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. L. S. R. Sadeck and J. L. A. Ramos, “Immune response of preterm infnats to hepatitis B vaccine administerd within 24 hours after birth,” Journal of Pediatrics, vol. 80, pp. 113–118, 2004.
  14. M. Soares, M. M. Mussi-Pinhata, S. M. Jorge, C. F. Tachibana, and C. Barbosa, “Immunogenicity of Hepatitis B vaccine in preterm and full term infants vaccinated within the first week of life,” Vaccine, vol. 20, no. 11-12, pp. 1557–1562, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Bhave, S. Bhise, S. C. Chavan, et al., “Hepatitis B vaccination in premature and low birth weight (LBW) babies,” Indian Pediatrics, vol. 39, no. 7, pp. 625–631, 2002. View at Scopus
  16. G. A. Losonsky, S. S. Wasserman, I. Stephens, et al., “Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization,” Pediatrics, vol. 103, no. 2, p. E14, 1999. View at Scopus
  17. N. K. Arora, S. Ganguly, S. N. Agadi, et al., “Hepatitis B immunization in low birthweight infants: do they need an additional dose?” Acta Paediatrica, vol. 91, no. 9, pp. 995–1001, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Linder, R. Handsher, B. German, et al., “Controlled trial of immune response of preterm infants to recombinant hepatitis B and inactivated poliovirus vaccines administered simultaneously shorly after birth,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 83, pp. F24–F27, 2000.
  19. O. Blondheim, D. Bader, M. Abend, et al., “Immunogenicity of hepatitis B vaccine in preterm infants,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 79, no. 3, pp. F206–F208, 1998. View at Scopus
  20. A. Sood, D. Singh, S. Mehta, V. Midha, and R. Kumar, “Response to hepatitis B vaccine in preterm babies,” Indian Journal of Gastroenterology, vol. 21, no. 2, pp. 52–54, 2002. View at Scopus
  21. G. Chirico, C. Belloni, A. Gasparoni, et al., “Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers,” Pediatrics, vol. 92, no. 5, pp. 717–719, 1993. View at Scopus
  22. M. Golewioska, D. Kardas-Sobantka, D. Chelbna-Sokol, and W. Sabanty, “Hepatitis B vaccination in preterm infants,” European Journal of Pediatrics, vol. 158, no. 4, pp. 293–297, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Chawareewong, A. Jirapongsa, and K. Lokaphadhana, “Immune response to hepatitis B vaccine in premature neonates,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 22, no. 1, pp. 39–40, 1991. View at Scopus
  24. F.-Y. Huang, P.-I. Lee, C.-Y. Lee, L.-M. Huang, L.-Y. Chang, and S.-C. Liu, “Hepatitis B vaccination in preterm infants,” Archives of Disease in Childhood: Fetal and Neonatal Edition, vol. 77, no. 2, pp. F135–F138, 1997. View at Scopus
  25. D. J. West, “Clinical experience with hepatitis B vaccines,” American Journal of Infection Control, vol. 17, no. 3, pp. 172–180, 1989. View at Scopus
  26. S. C. Kim, E. K. Chung, R. L. Hodinka, et al., “Immunogenicity of hepatitis B vaccine in preterm infants,” Pediatrics, vol. 99, no. 4, pp. 534–536, 1997. View at Scopus
  27. K. Kesler, J. Nasenbeny, R. Wainwright, B. Mcmahon, and L. Bulkow, “Immune responses of prematurely born infants to hepatitis B vaccination: results through three years of age,” Pediatric Infectious Disease Journal, vol. 17, no. 2, pp. 116–119, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. Nejedlá, “The development of immunological factors in infants with hyperbilirubinemia,” Pediatrics, vol. 45, no. 1, pp. 102–104, 1970. View at Scopus
  29. A. Ballesteros-Trujillo, A. Vargas-Origel, T. Alvarez-Muñoz, and C. Aldana-Valenzuela, “Response to hepatitis B vaccine in preterm infants: four-dose Schedule,” American Journal of Perinatology, vol. 18, no. 7, pp. 379–385, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. S. Sanpavat, Y. Poovorawan, S. Chittinand, S. Bhongsvej, and P. Thaithumyanon, “Immunogenicity of hepatitis B vaccine in premature infants,” The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 25, no. 1, pp. 93–95, 1994. View at Scopus
  31. C.-A. Siegrist, “Why are boosters no longer necessary for protection against hepatitis B?” Revue du Praticien, vol. 54, no. 5, pp. 509–511, 2004. View at Scopus
  32. J. E. Banatvala and P. van Damme, “Hepatitis B vaccine—do we need boosters?” Journal of Viral Hepatitis, vol. 10, no. 1, pp. 1–6, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. A. R. Zanetti, A. Mariano, L. Romano, et al., “Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study,” The Lancet, vol. 366, no. 9494, pp. 1379–1384, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. D.-S. Chen, “Long-term protection of hepatitis B vaccine: lessons from Alaskan experience after 15 years,” Annals of Internal Medicine, vol. 142, no. 5, pp. 384–385, 2005. View at Scopus
  35. N. Linder, T. H. Vishne, E. Levin, et al., “Hepatitis B vaccination: long-term follow-up of the immune response of preterm infants and comparison of two vaccination protocols,” Infection, vol. 30, no. 3, pp. 136–139, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. E. H. Boxall, J. A. Sira, N. El-Shuhkri, and D. A. Kelly, “Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low,” Journal of Infectious Diseases, vol. 190, no. 7, pp. 1264–1269, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus